KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)R&D In ProcessReceivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt repayments
Ratios

Novartis Ag (NVS) Receivables - Other (2017 - 2025)

Novartis Ag's Receivables - Other history spans 9 years, with the latest figure at $1.1 billion for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 4.01% to $1.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 billion, a 4.01% increase, with the full-year FY2025 number at $1.1 billion, up 4.01% from a year prior.
  • Receivables - Other hit $1.1 billion in Q4 2025 for Novartis Ag, up from $1.1 billion in the prior quarter.
  • Over the last five years, Receivables - Other for NVS hit a ceiling of $1.3 billion in Q4 2023 and a floor of $793.0 million in Q4 2021.
  • Historically, Receivables - Other has averaged $1.0 billion across 5 years, with a median of $1.1 billion in 2024.
  • Biggest five-year swings in Receivables - Other: decreased 17.65% in 2021 and later surged 30.69% in 2023.
  • Tracing NVS's Receivables - Other over 5 years: stood at $793.0 million in 2021, then rose by 20.81% to $958.0 million in 2022, then surged by 30.69% to $1.3 billion in 2023, then decreased by 12.38% to $1.1 billion in 2024, then increased by 4.01% to $1.1 billion in 2025.
  • Business Quant data shows Receivables - Other for NVS at $1.1 billion in Q4 2025, $1.1 billion in Q4 2024, and $1.3 billion in Q4 2023.